Cargando…
Downregulation of CUEDC2 prevents doxorubicin-induced cardiotoxicity in H9c2 cells
Treatment with doxorubicin (DOX), which is an effective anticancer agent, is limited by cardiotoxicity. CUE domain-containing 2 (CUEDC2) serves a role in numerous cellular processes. The present study aimed to elucidate the potential function of CUEDC2 in DOX-induced cardiotoxicity. Cell Counting ki...
Autores principales: | Zhang, Xianpu, Li, Jiaojiao, Cheng, Yongbo, Yi, Jianguang, Liu, Xin, Cheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059716/ https://www.ncbi.nlm.nih.gov/pubmed/29845245 http://dx.doi.org/10.3892/mmr.2018.9072 |
Ejemplares similares
-
Thrombopoietin protects H9C2 cells from excessive autophagy and apoptosis in doxorubicin-induced cardiotoxicity
por: Wang, Han, et al.
Publicado: (2018) -
The Prophylactic Effect of Pinocembrin Against Doxorubicin-Induced Cardiotoxicity in an In Vitro H9c2 Cell Model
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2020) -
Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes
por: Hwang, Soyoung, et al.
Publicado: (2022) -
CUEDC2 modulates cardiomyocyte oxidative capacity by regulating GPX1 stability
por: Jian, Zhao, et al.
Publicado: (2016) -
Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)